351 related articles for article (PubMed ID: 17591290)
1. Canine oral melanoma.
Bergman PJ
Clin Tech Small Anim Pract; 2007 May; 22(2):55-60. PubMed ID: 17591290
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor.
MacEwen EG; Kurzman ID; Vail DM; Dubielzig RR; Everlith K; Madewell BR; Rodriguez CO; Phillips B; Zwahlen CH; Obradovich J; Rosenthal RC; Fox LE; Rosenberg M; Henry C; Fidel J
Clin Cancer Res; 1999 Dec; 5(12):4249-58. PubMed ID: 10632367
[TBL] [Abstract][Full Text] [Related]
3. Efficient adenovector CD40 ligand immunotherapy of canine malignant melanoma.
von Euler H; Sadeghi A; Carlsson B; Rivera P; Loskog A; Segall T; Korsgren O; Tötterman TH
J Immunother; 2008 May; 31(4):377-84. PubMed ID: 18391758
[TBL] [Abstract][Full Text] [Related]
4. [Case report: oral malignant melanoma in an 11-month-old Dobermann].
Ballinari U; Schiller I; Schroff-Ballinari A; Mazzi M
Schweiz Arch Tierheilkd; 1998; 140(3):110-3. PubMed ID: 9528347
[TBL] [Abstract][Full Text] [Related]
5. Analysis of prognostic factors and patterns of failure in dogs with malignant oral tumors treated with megavoltage irradiation.
Théon AP; Rodriguez C; Madewell BR
J Am Vet Med Assoc; 1997 Mar; 210(6):778-84. PubMed ID: 9074679
[TBL] [Abstract][Full Text] [Related]
6. Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center.
Bergman PJ; Camps-Palau MA; McKnight JA; Leibman NF; Craft DM; Leung C; Liao J; Riviere I; Sadelain M; Hohenhaus AE; Gregor P; Houghton AN; Perales MA; Wolchok JD
Vaccine; 2006 May; 24(21):4582-5. PubMed ID: 16188351
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial.
Bergman PJ; McKnight J; Novosad A; Charney S; Farrelly J; Craft D; Wulderk M; Jeffers Y; Sadelain M; Hohenhaus AE; Segal N; Gregor P; Engelhorn M; Riviere I; Houghton AN; Wolchok JD
Clin Cancer Res; 2003 Apr; 9(4):1284-90. PubMed ID: 12684396
[TBL] [Abstract][Full Text] [Related]
8. [Combined use of irradiation and DNA tumor vaccine to treat canine oral malignant melanoma: a pilot study].
Herzog A; Buchholz J; Ruess-Melzer K; Lang J; Kaser-Hotz B
Schweiz Arch Tierheilkd; 2013 Feb; 155(2):135-42. PubMed ID: 23385072
[TBL] [Abstract][Full Text] [Related]
9. Oral malignant melanoma: a review of the literature.
Meleti M; Leemans CR; Mooi WJ; Vescovi P; van der Waal I
Oral Oncol; 2007 Feb; 43(2):116-21. PubMed ID: 16931116
[TBL] [Abstract][Full Text] [Related]
10. Tumor size and depth in primary malignant melanoma in the oral cavity influences survival.
Mücke T; Hölzle F; Kesting MR; Loeffelbein DJ; Robitzky LK; Hohlweg-Majert B; Tannapfel A; Wolff KD
J Oral Maxillofac Surg; 2009 Jul; 67(7):1409-15. PubMed ID: 19531410
[TBL] [Abstract][Full Text] [Related]
11. [A clinical and pathological study on primary oral mucosal malignant melanoma].
Chen Y; He Z; Wu L
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Feb; 21(1):31-3. PubMed ID: 12674617
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical characterization and evaluation of prognostic factors in canine oral melanomas with osteocartilaginous differentiation.
Sánchez J; Ramirez GA; Buendia AJ; Vilafranca M; Martinez CM; Altimira J; Navarro JA
Vet Pathol; 2007 Sep; 44(5):676-82. PubMed ID: 17846240
[TBL] [Abstract][Full Text] [Related]
13. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
[TBL] [Abstract][Full Text] [Related]
14. Megavoltage irradiation of neoplasms of the nasal and paranasal cavities in 77 dogs.
Théon AP; Madewell BR; Harb MF; Dungworth DL
J Am Vet Med Assoc; 1993 May; 202(9):1469-75. PubMed ID: 8496103
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of prognostic factors for dogs with primary lung tumors: 67 cases (1985-1992).
McNiel EA; Ogilvie GK; Powers BE; Hutchison JM; Salman MD; Withrow SJ
J Am Vet Med Assoc; 1997 Dec; 211(11):1422-7. PubMed ID: 9394893
[TBL] [Abstract][Full Text] [Related]
16. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
17. In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma.
Dow SW; Elmslie RE; Willson AP; Roche L; Gorman C; Potter TA
J Clin Invest; 1998 Jun; 101(11):2406-14. PubMed ID: 9616212
[TBL] [Abstract][Full Text] [Related]
18. Multimodality treatment including ONCEPT for canine oral melanoma: A retrospective analysis of 131 dogs.
Turek M; LaDue T; Looper J; Nagata K; Shiomitsu K; Keyerleber M; Buchholz J; Gieger T; Hetzel S
Vet Radiol Ultrasound; 2020 Jul; 61(4):471-480. PubMed ID: 32323424
[TBL] [Abstract][Full Text] [Related]
19. Classification and staging of melanoma.
Gershenwald JE; Buzaid AC; Ross MI
Clin Lab Med; 2000 Dec; 20(4):785-815. PubMed ID: 11221515
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of survival time in dogs with stage III osteosarcoma that undergo treatment: 90 cases (1985-2004).
Boston SE; Ehrhart NP; Dernell WS; Lafferty M; Withrow SJ
J Am Vet Med Assoc; 2006 Jun; 228(12):1905-8. PubMed ID: 16784383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]